Position in INSM
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$12,100,480
-$778,480 QoQ
Shares Held
74,000
0.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026KLP KAPITALFORVALTNING AS holds $233,352,994 across 145 Biotechnology names. INSM ranks #5 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
58,308 | $45,051,093 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
95,381 | $42,591,431 | |
| 3 | INCY |
Incyte Corp
|
192,305 | $18,099,746 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
51,200 | $16,940,544 | |
| 5 | INSM |
INSMED Inc
This page
|
74,000 | $12,100,480 | |
| 6 | RPRX |
Royalty Pharma plc
|
158,200 | $7,588,854 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
60,500 | $5,883,625 | |
| 8 | EXEL |
Exelixis, Inc.
|
94,400 | $4,048,816 |
All Filings in INSM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,100,480 | 74,000 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $12,878,960 | 74,000 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $5,904,410 | 41,000 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $3,804,192 | 37,800 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,609,118 | 34,200 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,278,320 | 33,000 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||